EPLAW PATENT BLOG

NL – Biogen and Hoffman La Roche v. Celltrion and Mundipharma

Posted: May 31st, 2017

District Court The Hague, The Netherlands, 12 May 2017, Case No. ECLI:NL:RBDHA:2017:5035

Injunction against biosimilar of Retuximab denied. Reasonable chance that the patent will be invalidated due to added matter.

A copy of the judgment can be read here.

Leave a Reply